- Home
- CRBP vs BMR Comparison
CRBP vs BMR Comparison
Compare CRBP & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- BMR
- Stock Information
- Founded
- CRBP 2009
- BMR 2009
- Country
- CRBP United States
- BMR Israel
- Employees
- CRBP N/A
- BMR N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- BMR Computer Software: Prepackaged Software
- Sector
- CRBP Health Care
- BMR Technology
- Exchange
- CRBP Nasdaq
- BMR Nasdaq
- Market Cap
- CRBP 73.4M
- BMR 59.3M
- IPO Year
- CRBP N/A
- BMR 2023
- Fundamental
- Price
- CRBP $8.33
- BMR $3.19
- Analyst Decision
- CRBP Strong Buy
- BMR
- Analyst Count
- CRBP 10
- BMR 0
- Target Price
- CRBP $53.56
- BMR N/A
- AVG Volume (30 Days)
- CRBP 123.5K
- BMR 1.0M
- Earning Date
- CRBP 08-05-2025
- BMR 08-05-2025
- Dividend Yield
- CRBP N/A
- BMR N/A
- EPS Growth
- CRBP N/A
- BMR N/A
- EPS
- CRBP N/A
- BMR N/A
- Revenue
- CRBP N/A
- BMR $3,064,000.00
- Revenue This Year
- CRBP N/A
- BMR $21.21
- Revenue Next Year
- CRBP $150.03
- BMR N/A
- P/E Ratio
- CRBP N/A
- BMR N/A
- Revenue Growth
- CRBP N/A
- BMR 5.33
- 52 Week Low
- CRBP $4.64
- BMR $1.86
- 52 Week High
- CRBP $61.90
- BMR $6.59
- Technical
- Relative Strength Index (RSI)
- CRBP 54.09
- BMR 51.92
- Support Level
- CRBP $8.10
- BMR $2.88
- Resistance Level
- CRBP $9.45
- BMR $4.32
- Average True Range (ATR)
- CRBP 0.52
- BMR 0.31
- MACD
- CRBP -0.08
- BMR -0.04
- Stochastic Oscillator
- CRBP 55.74
- BMR 20.19
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.